市場調査レポート

商品コード

1593484

血液培養検査の市場規模・シェア・成長分析 (技術別、用途別、最終用途別、地域別)：産業予測 (2024～2031年)

Blood Culture Tests Market Size, Share, Growth Analysis, By Technique (Conventional, Automated), By Application (Bacterial Infections, Fungal Infections), By End Use (Hospital Laboratories, Reference Laboratories), By Region -Industry Forecast 2024-2031

出版日: 2024年11月08日
発行: SkyQuest
ページ情報: 英文 198 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,228円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 897,512円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,027,796円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の血液培養検査の市場規模は、2022年に61億6,000万米ドルと評価され、2023年の69億2,000万米ドルから2031年には175億米ドルに成長し、予測期間 (2024～2031年) に12.3%のCAGRで成長する見通しです。

世界の血液培養検査市場は、血流感染症（BSI）に対する革新的な診断製品の承認増加やBSIの有病率の上昇を背景に、大きな成長を遂げています。血液培養検査は、血流中の細菌や真菌などの有害な微生物を特定する上で非常に重要です。この診断手順では、血液サンプルを抽出し、無菌環境で培養してこれらの病原体の増殖を促進することで、敗血症のような重篤な状態につながる可能性のある感染症を特定することができます。タイムリーで正確な検査結果は、医療専門家が的を絞った抗菌薬治療を処方し、患者ケアを改善し、感染症の蔓延を抑え、回復の成果を高めるための指針として不可欠です。このような検査は、効果的な感染管理において極めて重要な役割を果たすため、需要が高まっています。

市場概要
消耗品
血液培養培地
好気性血液培養培地
小児好気性血液培養培地
嫌気性血液培養培地
結核菌血液培養培地
真菌/酵母血液培養培地
アッセイキット・試薬
血液培養アクセサリー
機器
自動血液培養システム
実験装置のサポート
インキュベーター
コロニーカウンター
顕微鏡
グラム染色装置
ソフトウェア・サービス

世界の血液培養検査の市場規模 (技術別)・CAGR (2024～2031年)

市場概要
培養ベーステクノロジー
分子技術
マイクロアレイ
PCR（ポリメラーゼ連鎖反応）
PNA-FiSH（ペプチド核酸-蛍光in situハイブリダイゼーション）
プロテオミクス技術

世界の血液培養検査の市場規模 (用途別)・CAGR (2024～2031年)

市場概要
菌血症
真菌血症
結核菌検出

世界の血液培養検査の市場規模 (エンドユーザー別)・CAGR (2024～2031年)

市場概要
病院検査室
参考検査室
学術用研究室
その他の検査室

世界の血液培養検査の市場規模・CAGR (2024～2031年)

北米 (手法別、製品別、技術別、用途別、エンドユーザー別)
- 米国
- カナダ
欧州 (手法別、製品別、技術別、用途別、エンドユーザー別)
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州
アジア太平洋 (手法別、製品別、技術別、用途別、エンドユーザー別)
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ (手法別、製品別、技術別、用途別、エンドユーザー別)
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (手法別、製品別、技術別、用途別、エンドユーザー別)
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021年～2023年）

主要企業プロファイル

Abbott (米国)
F. Hoffmann-La Roche Ltd (スイス)
Novartis AG (スイス)
Eli Lilly and Company (米国)
Merck & Co., Inc. (米国)
Thermo Fisher Scientific Inc. (米国)
Siemens (ドイツ)
Danaher Corporation (米国)
ZEPTOMETRIX (米国)
CytoTest Inc. (米国)
Devyser (スウェーデン)
Bruker (米国)
BIOMERIEUX (フランス)
Bayer AG (ドイツ)
BD (米国)

結論と推奨事項

Product Code: SQMIG35D2281

Global Blood Culture Tests Market size was valued at USD 6.16 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 17.50 billion by 2031, growing at a CAGR of 12.3% during the forecast period (2024-2031).

The global blood culture tests market is experiencing significant growth driven by the increasing approval of innovative diagnostic products for bloodstream infections (BSIs) and the rising prevalence of BSIs. Blood culture tests are critical in identifying harmful microorganisms such as bacteria or fungi in the bloodstream. This diagnostic procedure involves extracting a blood sample and cultivating it in a sterile environment to promote the growth of these pathogens, enabling the identification of infections that may lead to severe conditions like sepsis. Timely and accurate results are essential for guiding medical professionals in prescribing targeted antimicrobial treatments, improving patient care, reducing the spread of infections, and enhancing recovery outcomes. The demand for such tests is rising due to their crucial role in effective infection management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Culture Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Culture Tests Market Segmental Analysis

Global Blood Culture Tests Market is segmented based on the Method, Product, Technology, Application, End-Use, and Region. Based on Product, the market is segmented into Conventional/Manual Methods, Automated Methods. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Technology, the market is segmented into Culture-based Technology, Molecular Technology, Proteomics Technology. Based on Application, the market is segmented into Bacteremia, Fungemia, Mycobacterial Detection. Based on End Use, the market is segmented into Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Culture Tests Market

The rising global prevalence of bloodstream infections has significantly driven the demand for accurate and swift diagnostic solutions like blood culture tests. A 2023 World Health Organization report highlighted a notable rise in sepsis cases worldwide, underscoring the critical role of timely diagnosis in implementing effective treatment strategies. This growing urgency has led to increased investments in cutting-edge blood culture technologies, fueling advancements in the diagnostic solutions market aimed at combating infectious diseases. As a result, the blood culture tests market is experiencing accelerated growth, driven by the need for enhanced diagnostic accuracy and speed in addressing these life-threatening infections.

Restraints in the Global Blood Culture Tests Market

A significant restraint in the global blood culture tests market is the difficulty in interpreting blood culture results. Distinguishing between contaminants and clinically relevant pathogens requires specialized expertise, which can limit market growth by increasing reliance on skilled professionals and raising concerns about the accuracy of results. While improving training for medical personnel and enhancing reporting systems can help address these challenges, they do not fully resolve the complexities involved in interpreting the outcomes. This ongoing issue could hinder the widespread adoption and effectiveness of blood culture tests, as healthcare providers remain cautious about their reliability in diagnosing infections.

Market Trends of the Global Blood Culture Tests Market

One key trend in the global blood culture tests market is the growing emphasis on medical education and training programs. These initiatives are playing a pivotal role in raising awareness among healthcare professionals about the significant benefits of blood culture tests, particularly in the early and accurate diagnosis of sepsis. Workshops and seminars dedicated to sepsis management are becoming increasingly common, helping to underline the importance of timely blood culture testing. As awareness increases, it leads to improved patient care and creates crucial growth opportunities for the market. This heightened focus on education is driving the adoption of blood culture tests, further expanding their role in clinical settings.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Pricing Analysis

Global Blood Culture Tests Market Size by Method & CAGR (2024-2031)

Market Overview
Conventional/Manual Methods
Automated Methods

Global Blood Culture Tests Market Size by Product & CAGR (2024-2031)

Market Overview
Consumables
Blood Culture Media
Aerobic Blood Culture Media
Pediatric Aerobic Blood Culture Media
Anaerobic Blood Culture Media
Mycobacterial Blood Culture Media
Fungi/Yeast Blood Culture Media
Assay Kits & Reagents
Blood Culture Accessories
Instruments
Automated Blood Culture Systems
Supporting Laboratory Equipment
Incubators
Colony Counters
Microscopes
Gram Stainers
Software and Service

Global Blood Culture Tests Market Size by Technology & CAGR (2024-2031)

Market Overview
Culture-Based Technology
Molecular Technologies
Microarrays
PCR (Polymerase Chain Reaction)
PNA-FiSH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization)
Proteomics Technology

Global Blood Culture Tests Market Size by Application & CAGR (2024-2031)

Market Overview
Bacteremia
Fungemia
Mycobacterial Detection

Global Blood Culture Tests Market Size by End User & CAGR (2024-2031)

Market Overview
Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories

Global Blood Culture Tests Market Size & CAGR (2024-2031)

North America, (Method, Product, Technology, Application, End User)
- US
- Canada
Europe, (Method, Product, Technology, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Method, Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Method, Product, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Method, Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEPTOMETRIX (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoTest Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devyser (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOMERIEUX (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments